Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Which Index Funds Had Best Yearly Returns Historically reveals top performers by year, helping you compare success across funds.
25,767 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Oil prices stay elevated, lifting a near-term windfall for U.S. producers by roughly $63 billion. But a protracted Ir...
Nine months after Jim Cramer touted Energy Transfer as a top dividend pick for retirees, the stock has delivered on i...
Dream Finders Homes drives a hostile bid for Beazer as Sumitomo Forestry closes a $4.5 billion cash deal for Tri Poin...
Alphabet's Gemini 3.5 showcases bold AI ambitions, but the stock is sliding as investors reassess ROI and token-based...
SoftBank Group stock tumbled about 20% over the past five trading days as questions surrounding OpenAI funding and th...
Amid a volatile market and rate shock fears, one investor insists they can't stop buying this tech titan. Apple’s Ser...
Scott Galloway weighs in on Kara Swisher's podcast empire and why the industry resembles the NBA: a handful of stars ...
XRP prices hover near $1 as July opens, triggering another round of ripple (xrp) price predictions. Traders weigh whe...
Warren Buffett publicly stated he initiated Berkshire Hathaway’s larger stake in Alphabet, signaling a top-down push ...
As earnings season arrives, praxis medicines 2025 earnings offer a compelling snapshot of where the company stands. T...
C2 Financial announced a nationwide expansion to reclaim its No. 1 wholesale ranking. The plan centers on AI upgrades...